ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology
The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study | npj Aging
Single, Double & Triple Blind Study | Definition & Examples
Schematic representation of double-blind, randomized, controlled,... | Download Scientific Diagram
8. 7 Randomised, double-blind, placebo-controlled trials | Training manual | HIV i-Base
PDF] Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. | Semantic Scholar
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023 - Arthritis & Rheumatology - Wiley Online Library
The randomized, double-blind, placebo controlled crossover design.
Double-Blind Clinical Trials - INSTRUCTIONAL DESIGN BY TRACY CARROLL
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist | The
Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram
Influenza Vaccination after Myocardial Infarction - a randomized, double- blind, placebo-controlled, multicenter trial | tctmd.com
Cause of Disease Should be Considered in Randomized Double-Blind Clinical Trials
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia - eBioMedicine
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned - MedWorks Media